This year BioMed Central is pleased to be sponsoring MSF Scientific Day.
Streamed live online from the Royal Society of Medicine, London, MSF Scientific Day is a unique opportunity to showcase medical and scientific research carried out in MSF programmes around the world. Presenting and debating the findings from our research is vital to improve the quality of our humanitarian programmes and, by streaming the event online, we hope to engage the wider humanitarian and global health community in this discussion.
The agenda for this year’s MSF Scientific Day has now been finalised. The keynote speech by international health expert, co-founder of the Gapminder Foundation and TED talks alumnus
Acta Neuropathologica Communications (ANC), a new open access journal focusing on the pathology and mechanisms of neurological disease has launched today with BioMed Central. Led by Editor-in-Chief Werner Paulus, a Professor of Neuropathology at University Hospital Münster, the journal hopes to emulate the success of its older, sister journal, Acta Neuropathalogica published by Springer.
Like Acta Neuropathalogica, ANC will publish high quality research and aims to get a decision on manuscripts to authors within 11 days, however it differs in the fact that it will only publish manuscripts which require no or only minor revisions. Werner Paulus explains the rational for this policy in his launch Editorial “One of the chief complaints from …
Avian influenza A (H7N9) is a tricky version of bird flu which seems to be sweeping across China. At the end of April the WHO registered 126 cases and 24 deaths but as of the beginning of May according to the Chinese CDC, there have been 127 confirmed cases of H7N9 in mainland China with 26 deaths.
A lack of information about the virus and its mode of transmission has led to public concerns that H7N9 could be a pandemic waiting to happen. It is a difficult virus to track because its main hosts – birds – do not appear to show symptoms of infection.
But do humans need to be worried? The BBC hesitates with ‘yes and …
Each year BioMed Central’s Annual Research Awards celebrate excellence in scientific research made freely available through open access publishing within our portfolio of biology and medical journals. Now in their 7th year, they are intended to recognize the achievements of particular research teams in ten diverse subject-specific award categories spanning all areas of Biology, Medicine and Health Services Research. We also have an Open Data award recognizing leadership in the sharing of data and a Case Report of the Year Award for the best case report recognized for its originality and significance to clinical practice.We are pleased to announce the winners for the ten subject-specific award categories:
Animal Science, Veterinary Research and Zoology
Cancer sponsored by
BioMed Central welcomes antibodies-online.com , as the overall BioMed Central Research Award Sponsor for the 7th Annual Research Awards. This prestigious award celebrates the very best in open access research across all disciplines published in BioMed Central’s 250 journals for 2012.
antibodies-online.com is the biggest independent distributor for proteomics (eg. ELISA kits, antibodies, proteins) research worldwide serving universities and biotech companies in 53 different countries.
“At antibodies-online we accelerate research. We interact with the research community every day and are happy to sponsor the BioMed Central Overall Research Award winner 2012. The annual BioMed Central Research Awards have become a key event on the open access calendar. The awards program is an excellent …
Through BioMed Central’s partnership with Edanz, we are aiming to support authors to select the journal that best suits their research from the 350+ open access journals published by BioMed Central, Chemistry Central, and SpringerOpen.
The Journal Selector uses semantic technology to help authors quickly choose the open access journal that is right for their manuscript.
Authors can enter an abstract or description of their research and the Journal Selector provides a list of relevant open access journals. Matches to a journal are based on the similarity of the entered text to articles already published in that journal. We hope our authors find this a useful tool, so please do visit the website to try it out …
From 1 April 2013, all academics funded by Research Councils UK (RCUK) need to be compliant with a new open access policy. The policy requires grantees to make their research available via open access – either immediately via open access (OA) publishing, or via OA deposit of the author version in an archive –typically with an embargo period.
Immediate OA via OA publishing is the route strongly preferred by the research councils, and to reduce barriers to OA publishing, dedicated funds have been made available to all universities which receive RCUK funding to cover article processing charges.
The policy was announced last summer. Since then we have seen reams of media coverage, and more recently, a flurry of public …
On Wednesday 27 February, the newest addition to the BMC-series portfolio was launched. This marked a significant milestone for the BMC-series family of open access journals, as it was the first truly new journal since 2008.
View the story “BMC Psychology Launches!” on Storify
Rare diseases day February 28th 2013 aims to raise awareness of rare diseases and their impact on people’s lives. These diseases have a cost, not just to the people affected and their families, but also in medical care, lost earnings, and to pay for research into improving diagnosis and treatment.
Diseases are classified as ‘rare’ if they affect less than one in 2000 people. But in reality ‘rare diseases’ are not that rare. In the UK alone one in 17 people will be affected at some point in their lives, which equates to more than 3.5 million people. Most of these will be children, and 30% of individuals with a rare disease will die before they are five years old.
Journal of Venomous Animals and Toxins including Tropical Diseases has completed its transfer to BioMed Central. In doing so, JVATiTD becomes the 250th journal in the BioMed Central portfolio.
JVATiTD is the official journal of the Center for the Study of Venoms and Venomous Animals (CEVAP), a unit of São Paulo State University (UNESP). The journal is dedicated to research on all aspects of toxins, venomous animals and their derivative products, also welcoming submissions related to tropical diseases with a focus on infectious diseases, parasitology and immunology.
When it was founded by CEVAP in 1995, JVATiTD was the first electronic scientific journal …